Hester Biosciences Limited Total Liabilities

Latest as of September 2025: Rs3.24 Billion INR ≈ $35.06 Million USD

Hester Biosciences Limited total liabilities. Based on the latest financial reports, Hester Biosciences Limited (HESTERBIO) has total liabilities worth Rs3.24 Billion INR (≈ $35.06 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check HESTERBIO asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Hester Biosciences Limited (2006–2025)

Total liabilities of Hester Biosciences Limited from 2006 to 2025. This chart illustrates how Hester Biosciences Limited's total liabilities have evolved over time, based on quarterly financial data. Explore Hester Biosciences Limited strategic investment ratio to see how much of total assets are deployed in long-term investments.

Hester Biosciences Limited Competitors by Total Liabilities

The table below lists competitors of Hester Biosciences Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Gamania Digital Entertainment Co Ltd TWO:6180	Taiwan	NT$3.62 Billion
Taisun Enterprise Co Ltd TW:1218	Taiwan	NT$2.44 Billion
Peninsula Group Ltd TA:PEN	Israel	ILA1.23 Billion
KIP Real Estate Investment Trust KLSE:5280	Malaysia	RM727.93 Million
Hanjin Transportation Co. Ltd. KO:002320	Korea	₩2.81 Trillion
Jeju Bank KO:006220	Korea	₩8.30 Trillion
SuperX AI Technology Limited NASDAQ:SUPX	USA	$36.27 Million
Pitanium Ltd NASDAQ:PTNM	USA	$19.87 Million

Liability Composition Analysis (2006–2025)

This chart breaks down Hester Biosciences Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see HESTERBIO total asset value.

Liquidity & Leverage Metrics

Hester Biosciences Limited Total Liabilities Ratios Explained

Hester Biosciences Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.44	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.06	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.96	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.48	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hester Biosciences Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hester Biosciences Limited (2006–2025)

The table below shows the annual total liabilities of Hester Biosciences Limited from 2006 to 2025.

Year	Total Liabilities	Change
2025-03-31	Rs3.27 Billion ≈ $35.33 Million	-9.11%
2024-03-31	Rs3.59 Billion ≈ $38.88 Million	+41.84%
2023-03-31	Rs2.53 Billion ≈ $27.41 Million	-14.02%
2022-03-31	Rs2.95 Billion ≈ $31.88 Million	+68.35%
2021-03-31	Rs1.75 Billion ≈ $18.94 Million	-1.63%
2020-03-31	Rs1.78 Billion ≈ $19.25 Million	+50.46%
2019-03-31	Rs1.18 Billion ≈ $12.79 Million	+19.44%
2018-03-31	Rs990.40 Million ≈ $10.71 Million	+5.43%
2017-03-31	Rs939.35 Million ≈ $10.16 Million	+18.21%
2016-03-31	Rs794.66 Million ≈ $8.59 Million	+4.74%
2015-03-31	Rs758.73 Million ≈ $8.21 Million	+15.08%
2014-03-31	Rs659.34 Million ≈ $7.13 Million	+19.44%
2013-03-31	Rs552.05 Million ≈ $5.97 Million	+60.64%
2012-03-31	Rs343.66 Million ≈ $3.72 Million	-16.39%
2011-03-31	Rs411.02 Million ≈ $4.45 Million	+2.43%
2010-03-31	Rs401.26 Million ≈ $4.34 Million	+5.95%
2009-03-31	Rs378.73 Million ≈ $4.10 Million	+7.68%
2008-03-31	Rs351.73 Million ≈ $3.80 Million	-2.00%
2007-03-31	Rs358.92 Million ≈ $3.88 Million	+307.05%
2006-03-31	Rs88.17 Million ≈ $953.58K	--

About Hester Biosciences Limited

NSE:HESTERBIO India Drug Manufacturers - Specialty & Generic

Market Cap

$208.11 Million

Rs19.24 Billion INR

Market Cap Rank

#16173 Global

#827 in India

Share Price

Rs2262.10

Change (1 day)

-0.73%

52-Week Range

Rs1259.10 - Rs2545.00

All Time High

Rs3204.96